The antimycobacterial spectrum of clarithromycin, a new macrolide drug, was screened against 26 strains belonging to 18 species of mycobacteria by determining radiometric MICs by Bactec methodology at three different pHs, i.e., pH 6.0, 6.8, and 7.4. The MICs obtained at pH 7.4 were 1 to 2 or more dilutions lower in some of the species than those obtained at pH 6.8, whereas they were significantly higher at pH 6 Among the macrolides, the parent molecule erythromycin has not been widely used as an antimycobacterial agent, mainly because of its rapid acid degradation (2) and relatively low plasma levels (3). Among newer erythromycin derivatives studied, clarithromycin, which contains a methyl group at C-6 (2), was shown to possess high activity against the otherwise multiple-drug-resistant Mycobacterium avium complex organisms (7). Following these studies, we decided to screen the full antimycobacterial spectrum of this drug by using Bactec radiometric MIC determinations. As reports showing higher activity of clarithromycin at alkaline pH (1) questioned the screening of this drug at pH 6.8, we also decided to screen the MICs at three different pHs, i.e., at pH 6.0, 6.8, and 7.4. The choice of these pHs was based on analogies with three particular situations: pH 6.0 was chosen as close to the pH that may prevail intracellularly, pH 6.8 was taken as the standard pH used for drug screening for mycobacteria, and pH 7.4 was based on the physiological pH prevailing in the plasma.
promising activity against such potential pathogens as M. avium, M. scrofulaceum, M. szulgai, M. malmoense, M. xenopi, M. marinum, and M. kansasii and rare pathogens like M. chelonei.
Among the macrolides, the parent molecule erythromycin has not been widely used as an antimycobacterial agent, mainly because of its rapid acid degradation (2) and relatively low plasma levels (3) . Among newer erythromycin derivatives studied, clarithromycin, which contains a methyl group at C-6 (2), was shown to possess high activity against the otherwise multiple-drug-resistant Mycobacterium avium complex organisms (7) . Following these studies, we decided to screen the full antimycobacterial spectrum of this drug by using Bactec radiometric MIC determinations. As reports showing higher activity of clarithromycin at alkaline pH (1) questioned the screening of this drug at pH 6.8, we also decided to screen the MICs at three different pHs, i.e., at pH 6.0, 6.8, and 7.4. The choice of these pHs was based on analogies with three particular situations: pH 6.0 was chosen as close to the pH that may prevail intracellularly, pH 6.8 was taken as the standard pH used for drug screening for mycobacteria, and pH 7.4 was based on the physiological pH prevailing in the plasma.
The various mycobacterial species used in this investigation (see Table 1 a Al the MICs were determined radiometrically. In the cases of all strict pathogens and M. xenopi, the drug-ontaining vials were inoculated with 0.1 ml of a preculture grown to a Bactec growth index of about 500, whereas in all other cases, they were inoculated with 0.1 ml of a 1:10 diluted culture (except M. fiorudwum and M. chelone, which were inoculated with a 1:100 diluted primoculture). The values in each case were compared to a further 1:100 diluted inoculum-containing control vial.
bBactec PZA test medium with a pH of 6.0 was used. c Bactec 12B medium with a pH of 6.8 was used. dMedium pH was fixed to 7.4 with NaOH.
which clarithromycin activity may be routinely screened by clinical laboratories.
